Skip to main content

Cranial Stabilization Devices Market to Witness Upward Trend with Approval of Spinal Stabilization System

 


The cranial stabilization devices market is expected to witness significant growth in the foreseeable future due to various factors such as high incidence of neurological disorders, increasing geriatric population, and high number of emergency surgeries.

Impact of Neurological Disorders on Cranial Stabilization Devices Market Growth

Neurological disorders include, acute spinal cord injury, Alzheimer's disease, brain tumors, cerebral aneurysm, epilepsy, and others. Cranial stabilization devices are designed for patient positioning in the prone, supine, and sitting positions during surgeries involving the brain and neck. According to Alzheimer’s Association, around 5.8 million people in the U.S. aged 65 and older are living with Alzheimer's dementia in 2020. Such trend suggests high demand for cranial stabilization devices in North America.

The U.S is also witnessing high incidence of brain tumor. According to The Central Brain Tumor Registry of the United States (2020 CBTRUS Statistical Report), the incidence rate of all primary malignant and non-malignant brain and other central nervous system tumors in the U.S was 23.79 cases per 100,000 for a total count of 415,411 incident tumors. Such trend suggests high demand for cranial stabilization devices in the U.S.

Relation between Growing Geriatric Population and Growth of Cranial Stabilization Devices Market

Geriatric population is prone to various orthopedic and neurological diseases that involve use of cranial stabilization devices. According to United Nations Population Fund, geriatric population in Asia Pacific is expected to triple between 2010 and 2050 to reach 1.3 billion people by 2050. This also suggests significant demand for cranial stabilization devices in Asia Pacific.        

Geriatric population, as earlier mentioned, is vulnerable to orthopedic diseases. Treatment of such diseases may require the use of cranial stabilization devices. According to researchers at the National Spinal Cord Injury Statistical Center at University of Alabama at Birmingham, as of 2019, 17,730 new spinal cord injury cases occur annually and between 249,000 and 363,000 people are currently living with spinal cord injuries in the U.S.

New Developments in Cranial Stabilization Devices Market

In November 2020, the U.S. Food and Drug Administration gave 510(k) clearance to SeaSpine Holdings Corporation's Mariner Cap System that is used to offer temporary stabilization as a bone anchor during the development of solid bony fusion and aid in the repair of bone fractures. SeaSpine Holdings Corporation is a U.S.-based manufacturer of surgical solutions for the treatment of patients suffering from spinal disorders.

 

Comments

Popular posts from this blog

The Global Autoclave Equipment Market Continues To Grow Owing To the Rising Demand from Healthcare Sectors for Sterilizing Medical Equipment to Ensure the Safety of the Post-Surgical Period

  Autoclave equipment is the most popular sterilization method in the industry and is used for many applications including the manufacture of food products. It is widely used in the foodservice industry to sterilize and cleanse equipment used in the process of preparing and serving food. The autoclave is the abbreviated form of autolysis which means oxidation. Autoclaves have various parts including an electric motor, a condenser, and a burner. Autoclave equipment includes vials for sealing the autoclave, a glass or plastic container that has been lined with wax or plastic, and the appropriate autoclave equipment accessories such thermometer for measuring the temperature of the autoclave. All modern steam sterilizing equipment & autoclave machines provide a much-refined workflow experience, which makes you reconsider whether or not steam sterilizing is all it can be. A wide range of sterilization methods is used for sterilizing your medical and laboratory specimen so the right ...

Biologics Market Increasing Prevalence of Chronic Diseases to Augment Growth of the market

  A  biologic  drug ( biologics ) is a product that is produced from living organisms or contains components of living organisms.  Biologic  drugs are widely used to prevent, diagnose, treat, or cure a variety of diseases, including infectious diseases, autoimmune disorders, chronic kidney disease, and cancer. Market Dynamics In the recent past, several novel biopharmaceutical products were approved by major regulatory bodies and major players in the market have launched various novel and innovative biopharmaceutical products. Rapid approvals and launches of novel products in the market are expected to be major drivers for growth of the biologicsmarket . 

Treprostinil Drugs Market - High Prevalence of Pulmonary Arterial Hypertension and R&D of New Formulations of Treprostinil to Augment Growth of market

  Treprostinil is an antihypertensive agent used to treat patients with pulmonary arterial hypertension. It can also be used in the treatment of Degos disease, an extremely rare disorder in which small and medium sized arteries become blocked (occlusive arteriopathy), restricting the flow of blood to affected areas. Market Dynamics High prevalence of pulmonary arterial hypertension is expected to propel growth of the treprostinil drugs market . For instance, according to the study, ‘High Geographic Prevalence of Pulmonary Artery Hypertension: Associations with Ethnicity, Drug Use, and Altitude’, published in February 2020, in the journal Pulmonary Circulation, the overall pulmonary arterial hypertension incidence was 14 cases per million and the annual period prevalence of pulmonary arterial hypertension was 93 cases per million. Decline in new prescriptions for treprostinil-based products is expected to hinder growth of the treprostinil drugs market. For instance, United The...